"because they are young,
they are overlooked for
bowel cancer."
📈266%
increase in incidence rates of bowel/colorectal cancer in adolescents and young adults in the past three decades
Millennials are twice as likely to develop colon cancer and four times as likely to develop rectal cancer compared to people born in 1950.
we need you
to help us adapt the wellness message to improve focus on gut cancer and disease prevention
the opportunity
to partner with us and our passion and commitment to raising awareness
to initiate change and impact gut health awareness for the future
saving lives
how?
empower young people to take control and responsibility for their gut health via diverse:
-
experts
-
forums
-
films
-
events
giving them knowledge and understanding, encouraging questions curiosity and sharing
real change can only occur through collaboration between like-minded organisations so we are proud that our project is supported by Injoy
they couple evidence based information with an innovative AI-powered GutChat to empower those who struggle with gut issues to become “expert patients”.
EOCRC, also known as early-onset colorectal cancer, is predicted to be the leading cause of death in individuals aged 20 to 49 years in the USA by 2030, that is in only 7 years time. Already, cases are increasing dramatically in people below 30 in many countries, including low and middle-income
We have a 3 year ongoing strategy
year 1
-
market research /pan-European focus groups to assess young attitudes and expectations, cancer awareness, global trends and science across all socio economic groups
-
secure partnerships with relevant stakeholders – influencers, organisations, church leaders, community groups etc
-
develop the Inside Out brand
-
appoint expert advisors to the project panel
about us
Jola Gore Booth's association with patient advocacy begun in 1996 when she was appointed CEO of Colon Cancer Concern (now Bowel Cancer UK), prior to which she worked as a fundraiser in Trinity Hospice UK
In 2004 she launched and became the CEO of Europacolon – the first pan European not-
for-profit CRC patient advocacy organisation. Jola believed strongly in the importance of
collaboration and creating Europe wide CRC communities and later expanded Europacolon into Digestive Cancers Europe, remaining as Director until 2021.
In 2007 she designed and produced the first inflatable walk through colon/bowel to raise
awareness on the risks, signs and symptoms of CRC
in 2021 Jola took the decision to use and expand her skills and set up a new not-for-profit Global Healthcare Projects